339 related articles for article (PubMed ID: 11360214)
1. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia.
Giamarellos-Bourboulis EJ; Grecka P; Poulakou G; Anargyrou K; Katsilambros N; Giamarellou H
Clin Infect Dis; 2001 Jun; 32(12):1718-25. PubMed ID: 11360214
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
[TBL] [Abstract][Full Text] [Related]
3. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.
Jimeno A; García-Velasco A; del Val O; González-Billalabeitia E; Hernando S; Hernández R; Sánchez-Muñoz A; López-Martín A; Durán I; Robles L; Cortés-Funes H; Paz-Ares L
Cancer; 2004 Jun; 100(11):2462-9. PubMed ID: 15160353
[TBL] [Abstract][Full Text] [Related]
4. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
5. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients?
Shomali W; Hachem R; Chaftari AM; Jiang Y; Bahu R; Jabbour J; Raad S; Al Shuaibi M; Al Wohoush I; Raad I
Cancer; 2012 Dec; 118(23):5823-9. PubMed ID: 22605389
[TBL] [Abstract][Full Text] [Related]
6. Serial procalcitonin levels to detect bacteremia in febrile neutropenia.
Reitman AJ; Pisk RM; Gates JV; Ozeran JD
Clin Pediatr (Phila); 2012 Dec; 51(12):1175-83. PubMed ID: 23034950
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
[TBL] [Abstract][Full Text] [Related]
8. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia.
Gac AC; Parienti JJ; Chantepie S; Fradin S; Le Coutour X; Leclercq R; Reman O
Leuk Res; 2011 Oct; 35(10):1294-6. PubMed ID: 21831426
[TBL] [Abstract][Full Text] [Related]
10. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
[TBL] [Abstract][Full Text] [Related]
12. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
13. Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?
Robinson JO; Lamoth F; Bally F; Knaup M; Calandra T; Marchetti O
PLoS One; 2011 Apr; 6(4):e18886. PubMed ID: 21541027
[TBL] [Abstract][Full Text] [Related]
14. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin predicts real-time PCR results in blood samples from patients with suspected sepsis.
Mencacci A; Leli C; Cardaccia A; Meucci M; Moretti A; D'Alò F; Farinelli S; Pagliochini R; Barcaccia M; Bistoni F
PLoS One; 2012; 7(12):e53279. PubMed ID: 23300907
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin as a useful marker of infection in hemato-oncological patients with fever.
Sandri MT; Passerini R; Leon ME; Peccatori FA; Zorzino L; Salvatici M; Riggio D; Cassatella C; Cinieri S; Martinelli G
Anticancer Res; 2008; 28(5B):3061-5. PubMed ID: 19031957
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin--A New Marker in Febrile Neutropenia: Comparison With CRP and Procalcitonin.
Demirkaya M; Tugcu D; Akcay A; Aydogan G; Akıcı F; Salcioglu Z; Ekmekci H; Sevinir B; Balci Ekmekci O
Pediatr Hematol Oncol; 2015; 32(7):482-9. PubMed ID: 26271020
[TBL] [Abstract][Full Text] [Related]
18. Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever.
Kim MH; Lim G; Kang SY; Lee WI; Suh JT; Lee HJ
Yonsei Med J; 2011 Mar; 52(2):276-81. PubMed ID: 21319346
[TBL] [Abstract][Full Text] [Related]
19. Role of procalcitonin in the diagnosis of severe infection in pediatric patients with fever and Neutropenia--a systemic review and meta-analysis.
Lin SG; Hou TY; Huang DH; He SY; Lin YD; Zhang LY; Hsieh PS
Pediatr Infect Dis J; 2012 Oct; 31(10):e182-8. PubMed ID: 22592515
[TBL] [Abstract][Full Text] [Related]
20. Changes in circulating procalcitonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients.
Hoeboer SH; Groeneveld AB
PLoS One; 2013; 8(6):e65564. PubMed ID: 23762396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]